CC
ARDT

Conversant Capital’s Ardent Health ARDT Stock Holding History

Conversant Capital’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-70,917
Closed -$1.3M – 21
2024
Q3 		$1.3M Buy
+70,917
New +$1.25M 0.14% 19

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $80M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Conversant Capital's ARDT Position: Q4 2024 in Review

Conversant Capital sold out of Ardent Health (ARDT) in Q4 2024, closing a stake of 70,917 shares — an estimated $1.3M sold.

Conversant Capital first reported a position in ARDT in Q3 2024 and held it in 1 quarter. The position peaked at $1.3M in Q3 2024. 89 funds tracked by Wall St. Rank hold ARDT as of Q4 2024.

  • Conversant Capital reported no remaining Ardent Health position as of Q4 2024 after selling out during the quarter.
  • Conversant Capital sold 70,917 Ardent Health shares in Q4 2024, an estimated $1.3M.
  • Conversant Capital first reported a position in Ardent Health in Q3 2024 and held it in 1 quarter.
  • Conversant Capital's Ardent Health position peaked at $1.3M in Q3 2024.
  • 89 funds tracked by Wall St. Rank held Ardent Health as of Q4 2024.

Based on Conversant Capital's 13F filing for Q4 2024, filed 14 Feb 2025.